Abbott Laboratories (ABT)
105.27
-0.63
(-0.59%)
USD |
NYSE |
Apr 18, 16:00
105.83
+0.56
(+0.53%)
After-Hours: 20:00
Abbott Laboratories Cash from Investing (TTM): -3.133B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -3.133B |
September 30, 2023 | -2.941B |
June 30, 2023 | -2.791B |
March 31, 2023 | -1.842B |
December 31, 2022 | -1.74B |
September 30, 2022 | -1.779B |
June 30, 2022 | -1.946B |
March 31, 2022 | -1.946B |
December 31, 2021 | -2.008B |
September 30, 2021 | -2.068B |
June 30, 2021 | -1.889B |
March 31, 2021 | -2.244B |
December 31, 2020 | -2.215B |
September 30, 2020 | -1.973B |
June 30, 2020 | -1.933B |
March 31, 2020 | -1.812B |
December 31, 2019 | -1.815B |
September 30, 2019 | -1.822B |
June 30, 2019 | -1.713B |
March 31, 2019 | -1.514B |
December 31, 2018 | -1.356B |
September 30, 2018 | -4.012B |
June 30, 2018 | -3.995B |
March 31, 2018 | -3.702B |
December 31, 2017 | -9.618B |
Date | Value |
---|---|
September 30, 2017 | -4.916B |
June 30, 2017 | -5.164B |
March 31, 2017 | -6.628B |
December 31, 2016 | -248.00M |
September 30, 2016 | -232.00M |
June 30, 2016 | -875.00M |
March 31, 2016 | 837.00M |
December 31, 2015 | 406.00M |
September 30, 2015 | -1.17B |
June 30, 2015 | -798.00M |
March 31, 2015 | 188.00M |
December 31, 2014 | -202.00M |
September 30, 2014 | 648.00M |
June 30, 2014 | -1.224B |
March 31, 2014 | -2.416B |
December 31, 2013 | -3.929B |
September 30, 2013 | -5.994B |
June 30, 2013 | -3.429B |
March 31, 2013 | -2.776B |
December 31, 2012 | -5.56B |
September 30, 2012 | -2.570B |
June 30, 2012 | -1.447B |
March 31, 2012 | -1.930B |
December 31, 2011 | 661.00M |
September 30, 2011 | -3.544B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-3.133B
Minimum
Dec 2023
-1.713B
Maximum
Jun 2019
-2.085B
Average
-1.946B
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
Stryker Corp | -962.00M |
Boston Scientific Corp | -2.574B |
Edwards Lifesciences Corp | 173.80M |
Insulet Corp | -119.40M |
Intuitive Surgical Inc | -360.10M |